3rd Quarter - Report

THE ERISA INDUSTRY COMMITTEE for ERISA INDUSTRY COMMITTEE

Firm
Client
Income
—
Expenses
$60,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Retirement RET

FAMILY Act and other paid leave issues General issues and regulations on retirement Securing a Strong Retirement Act of 2021 (SSA) Retirement Security and Savings Act Enhancing Emergency and Retirement Savings Act of 2021 Building an Economy for Families Act Single-Employer Defined Benefit Issues Build Back Better Act

LobbyistCovered position, as disclosed
ANDREW BANDUCCI New Professional Staff Member and Workforce Policy Counsel, House Comm. on Education and the Workforce;Labor and Pensions Policy Director, Sen. HELP Comm.;Chief Policy Officer, Pension Benefit Guaranty Corp;Pensions Detailee, Sen. Finance Comm.
CHRISTINA CICONTE —
ANNETTE GUARISCO FILDES —
ALIYA S ROBINSON —

Contacted: Internal Revenue Service (IRS); Treasury, Dept of; Labor, Dept of (DOL); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Council of Economic Advisers (CEA); Equal Employment Opportunity Commission (EEOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Natl Economic Council (NEC)

Health Issues HCR

COVID Legislation, Price gouging, Testing, American Rescue Plan Act, Build Back Better legislation Affordable Care Act, all provisions and related regulations, including Reporting (IRC 6055 and 6056); Employer mandate; wellness issues; out-of-pocket (OOP) limits, nondiscrimination, 1332 waivers, ADA and GINA, PCORI & comparative effectiveness, Coverage mandates on ERISA plans HIPAA compliance, Privacy, Claims data and all payers claims databases Mental Health Parity, Substance use disorders, Opioids mitigation Tax Treatment of Employer-Sponsored Health Insurance Prescription Drug Costs, Rebates, Biosimilars, Rx supply chain, Vaccines Value-Driven Care in Public and Private Coverage, Patient Safety Medicare Advantage, Medicare Secondary Payer, End Stage Renal Disease (ESRD) Retiree health, COBRA, Medicare expansion and Public option Health Savings Accounts, HDHP coverage of telehealth, Onsite clinics, Infectious disease ERISA Preemption, State mandates & assessments Lower Health Care Costs Act, Transparency and Accountability in the health care system Surprise medical billing Telehealth expansion, Interstate provider licensing Commonsense Reporting Act, patient safety

LobbyistCovered position, as disclosed
CHRISTINA CICONTE —
JAMES PATRICK GELFAND —
ANNETTE GUARISCO FILDES —

Contacted: Council of Economic Advisers (CEA); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Labor, Dept of (DOL); Executive Office of the President (EOP); Treasury, Dept of; Centers For Medicare and Medicaid Services (CMS); SENATE; Equal Employment Opportunity Commission (EEOC); Natl Economic Council (NEC); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.